Prodromal symptoms in adolescents with 22q11.2 deletion syndrome and schizotypal personality disorder

Schizophrenia Research

Volumn 129, Issue 1, 2011, Pages 20-28

  Shapiro, D I ^a   Cubells, J F ^b   Ousley, O Y ^b   Rockers, K ^b   Walker, E F ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

22q11.2 Deletion Syndrome; Genetic deletion syndrome; Prodrome; Psychosis; Schizotypal personality disorder; Ultra high risk

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD BEHAVIOR; CHROMOSOME DELETION 22Q11; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC RISK; HEBEPHRENIA; HIGH RISK PATIENT; HUMAN; MALE; MOOD DISORDER; MOTOR DYSFUNCTION; NEGATIVE SYNDROME; PATHOGENESIS; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOSIS; RISK ASSESSMENT; SCHIZOTYPAL PERSONALITY DISORDER; SLEEP DISORDER; SYMPTOMATOLOGY; TREND STUDY;

ADOLESCENT; CASE-CONTROL STUDIES; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; DIGEORGE SYNDROME; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOTYPAL PERSONALITY DISORDER;

EID: 79956220348     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.03.030     Document Type: Article

References (58)

1. Antshel K.M., Shprintzen R., Fremont W., Higgins A.M., Faraone S.V., Kates W.R. Cognitive and psychiatric predictors to psychosis in Velocardiofacial Syndrome: a 3-year follow-up study. J. Am. Acad. Child Psychiatry 2010, 49(4):333-344.
2. Basset A.S., Chow E.W.C., AbdelMalik P., Gheorghiu M., Husted J., Weksberg R. The schizophrenia phenotype in 22q11 deletion syndrome. Am. J. Psychiatry 2003, 160:1580-1586.
3. Botto L.D., May K., Fernhoff P.M., Correa A., Coleman K., Rasmussen S.A., Merritt R.K., O'Leary L.A., Wong L.Y., Elixson E.M., Mahle W.T., Campbell R.M. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 2003, 112(pt 1):101-107. 1.
4. Cannon T.D., Cadenhead K., Cornblatt B., Woods S.W., Addington J., Walker E., Seidman L.J., Perkins D., Tsuang M., McGlashan T., Heinssen R. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch. Gen. Psychiatry 2008, 65(1):28-37.
5. Chow E.W.C., Watson M., Young D.A., Bassett A.S. Neurocognitive profile in 22q11 deletion syndrome and schizophrenia. Schizophr. Res. 2006, 87:270-278.
6. Dickey C.C., McCarley R.W., Niznikiewicz M.A., Voglmaier M.M., Seidman L.J., Kim S., Shenton M.E. Clinical, cognitive, and social characteristics of a sample of neuroleptic-naïve persons with schizotypal personality disorder. Schizophr. Res. 2005, 78:297-308.
7. Eliez S., Schmitt J.E., White C.D., Reiss A.L. Children and adolescents with velocardiofacial syndrome: a volumetric MRI study. Am. J. Psychiatry 2000, 157(3):409-415.
8. Erlenmeyer-Kimling L. Neurobehavioral deficits in offspring of schizophrenic parents: liability indicators and predictors of illness. Am. J. Med. Genet. 2000, 97(1):65-71.
9. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV-clinical version (SCID-CV) (User's Guide and Interview) 1997, American Psychiatric Press, Inc., Washington, D.C.
10. Goldberg R., Motzkin B., Marion R., Scambler P.J., Shprintzen R.J. Velo-cardio-facial syndrome: a review of 120 patients. Am. J. Med. Genet. 1993, 45:313-319.
11. Goodship J., Cross I., LiLing J., Wren C. A population study of chromosome 22q11 deletions in infancy. Arch. Dis. Child. 1998, 79:348-351.
12. Gothelf D., Feinstein C., Thompson T., Gu E., Penniman L., Van Stone E., Kwon H., Eliez S., Reiss A.L. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. Am. J. Psychiatry 2007, 164(4):663-669.
13. Henry J.C., van Amelsvoort T., Morris R.G., Owen M.J., Muphry D.G.M., Muphy K.C. An investigation of the neuropsychological profile in adults with velo-cardio-facial syndrome (VCFS). Neuropsychologia 2002, 40:471-478.
14. Hoogendoorn M.L., Vorstman J.A., Jalali G.R., Selten J.P., Sinke R.J., Emanuel B.S., Kahn R.S. Prevalence of 22q11.2 deletions in 311 Dutch patients with schizophrenia. Schizophr. Res. 2008, 98:84-88.
15. Horowitz A., Shifman S., Rivlin N., Pisante A., Darvasi A. A survey of the 22q11 microdeletion in a large cohort of schizophrenia patients. Schizophr. Res. 2005, 73:263-267.
16. Ivanov D., Kirov G., Norton N., Williams H.J., Williams N.M., Nikolov I., Tzwetkova R., Stambolova S.M., Murphy K.C., Toncheva D., Thapar A., O'Donovan M.C., Owen M.J. Chromosome 22q11 deletions, velo-cardio-facial syndrome and early-onset psychosis; Molecular genetic study. Br. J. Psychiatry 2003, 183:409-413.
17. Karayiorgou M., Morris M.A., Morrow B., Shprintzen R.J., Goldberg R., Borrow J., Gos A., Nestadt G., Wolyniec P.S., Lasseter V.K., Eisen H., Childs B., Kazazian H.H., Kucherlapati R., Antonarakis S.E., Pulver A.E., Housman D.E. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc. Natl. Acad. Sci. USA 1995, 92:7612-7616.
18. Kendler K.S., Gruenberg A.M., Strauss J.S. An independent analysis of the Copenhagen sample of the Danish adoption study of Schizophrenia. II. The relationship between schizotypal personality disorder and Schizophrenia. Arch. Gen. Psychiatry 1981, 38(9):982-984.
19. Kendler K.S., Neale M.C., Walsh D. Evaluating the spectrum concept of schizophrenia in the Roscommon family study. Am. J. Psychiatry 1995, 152(5):749-754.
20. Kiley-Brabeck K., Sobin C. Social skills and executive function deficits in children with the 22q11 Deletion Syndrome. Appl. Neuropsychol. 2006, 13(4):258-268.
21. Klosterkotter J., Hellmich M., Steinmeyer E.M., Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch. Gen. Psychiatry 2001, 58(2):158-164.
22. Lemos S., Vallina O., Fernandez P., Ortega J.A., Garcia P., Gutierrez A., Bobes J., Garcia A., Miller T. Predictive validity of the scale of prodromal symptoms (SOPS). Actas Esp. Psiquiatr. 2006, 34(4):216-223.
23. Loewy R.L., Johnson J.K., Cannon T.D. Self-report of attenuated psychotic experiences in a college population. Schizophr. Res. 2007, 93:144-151.
24. McGlashan T.H., Miller T.J., Woods S.W., Rosen J.L., Hoffman R.E., Davidson L. Structured Interview for Prodromal Syndromes (SIPS) 2001, Yale University, New Haven.
25. Meyer S.E., Bearden C.E., Lux S.R., Gordon J.L., Johnson J.K., O'Brien M.P., Niendam T.A., Loewry R.L., Ventura J., Cannon T.D. The psychosis prodrome in adolescent patients viewed through the lens of DSM-IV. J. Child Adolesc. Psychopharmacol. 2005, 15(3):434-451.
26. Miller T.J., McGlashan T.H., Rosen J.L., Somjee L., Markovich, Stein K., Woods S.W. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am. J. Psychiatry 2002, 159(5):863-865.
27. Miller T.J., McGlashan T.H., Rosen J.L., Cadenhead K., Ventura J., McFarlane W., Perkins D.O., Pearlson G.D., Woods S.W. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr. Bull. 2003, 29(4):703-715.
28. Mittal V.A., Dhruv S., Tessner K.D., Walder D., Walker E.F. The relations among putative bio risk markers in schizotypal adolescents: minor physical anomalies, movement abnormalities and salivary cortisol. Biol. Psychiatry 2007, 61(10):1179-1186.
29. Mittal V.A., Tessner K.D., Trottman H.D., Esterberg M., Dhrub S.H., Simeonova D.I., McMillan A.L., Murphy E., Saczawa M.E., Walker E.F. Movement abnormalities and the progression of prodromal symptomatology in adolescents at risk for psychotic disorders. J. Abnorm. Psychol. 2007, 116(2):260-267.
30. Mittal V.A., Saczawa M.E., Walder D., Willhite R., Walker E.F. Prenatal exposure to viral infection and conversion among male adolescents at high-risk for psychotic disorders. Schizophr. Res. 2008, 99(1-3):375-376.
31. Morgan C., Fisher H., Hutchinson G., Kirkbride J., Craig T.K., Morgan K., Dazzan P., Boydell J., Doody G.A., Jones P.B., Murray R.M., Leff J., Fearon P. Ethnicity, social disadvantage and psychotic-like experiences in a healthy population based sample. Acta Psychiatr. Scand. 2009, 119(3):226-235.
32. Muphy K.C., Jones L.A., Owen M.J. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch. Gen. Psychiatry 1999, 56(10):940-945.
33. Neumann C.S., Walker E.F. Motor dysfunction in schizotypal personality disorder. Schizophr. Res. 1999, 38(2-3):159-168.
34. Oskarsdottir S., Vujic M., Fasth A. Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch. Dis. Child. 2004, 89(2):148-151.
35. Palmer B.W., Taylor M.J., Heaton R.K. Accuracy of WAIS-III-WMS-III joint factor scores when one or more subtests is omitted or an alternate subtest is employed. Clinical interpretation of the WAIS-III and WMS-III 2003, 391-450. Academic Press, San Diego. D.S. Tulsky, D.H. Saklofske, G.J. Chelune, R.K. Heaton, R.J. Ivnik, R. Bornstein, A. Prifitera, M.F. Ledbetter (Eds.).
36. Pfohl B., Blum N., Zimmerman M. Structured interview for DSM-IV personality: SIDP-IV 1995, American Psychiatric Press, Washington DC.
37. Pulver A.E., Nestadt G., Goldberg R., Shprintzen R.J., Lamacz M., Wolyniec P.S., Morrow B., Karayiorgou M., Antonarakis S.E., Housman D., Kucheriapati R. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J. Nerv. Ment. Dis. 1994, 182:476-478.
38. Ramsey P.H., Ramsey P.P. Power and type I errors for pairwise comparisons of means in the unequal variances case. Br. J. Math. Stat. Psychol. 2009, 62:263-281.
39. Ringe W.K., Saine K.C., Lacritz L.H., Hynan L.S., Munro Cullum C. Dyadic short forms of the Wechsler Adult Intelligence Scale-III. Assessment 2002, 9(3):254-260.
40. Rockers K., Ousley O., Sutton T., Schoenberg E., Coleman K., Walker E., Cubells J.F. Performance on the Modified Card Sorting Test and its relation to psychopathology in adolescents and young adults with 22q11.2 deletion syndrome. J. Intellect. Disabil. Res. 2009, 53(7):665-676.
41. Rossler W., Riecher-Rossler A., Angst J., Murray R., Gamma A., Eich D., van Os J., Gross V.A. Psychotic experiences in the general population: a twenty-year prospective community study. Schizophr. Res. 2007, 92(1-3):1-14.
42. Ryan A.K., Goodship J.A., Wilson D.I., Philip N., Levy A., Seidel H. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J. Med. Genet. 1997, 42:1141-1142.
43. Ryan J.J. Clinical utility of a WISC-R short form. J. Clin. Psychol. 1981, 37(2):389-391.
44. Ryan J.J. Clinical utility of a WAIS-R short form. J. Clin. Psychol. 1983, 39(2):261-262.
45. Shprintzen R.J., Goldberg R., Golding-Kushner K.J., Marion R.W. Late-onset psychosis in the velo-cardio-facial syndrome (letter). Am. J. Med. Genet. 1992, 42:141-142.
46. Simon T.J., Ding L., Bish J.P., McDonald-McGinn D.M., Zackai E.H., Gee J. Volumetric, connective, and morphologic changes in the brains of children with chromosome 22q11.2 deletion syndrome: an integrative study. Neuroimage 2005, 25(1):169-180.
47. Sobin C., Monk S.H., Kiley-Brabeck K., Khuri J., Karayiorgou M.V. Neuromotor deficits in children with the 22q11 deletion syndrome. Mov. Disord. 2006, 21(12):2082-2089.
48. Stoddard J., Niendam T., Hendren R., Carter C., Simon T.J. Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome. Schizophr. Res. 2010, 118:118-121.
49. Swillen A., Devriendt K., Legius E., Prinzie P., Vogels A., Ghesquiere P., Fryns J.P. The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence. Genet. Couns. 1999, 10(1):79-88.
50. Van Aken K., De Smedt B., Van Roie A., Gewillig M., Devriendt K., Fryns J.P., Simons J., Swillen A. Motor develop ment in school-aged children with 22q11 deletion (velocardiofacial/DiGeorge syndrome). Dev. Med. Child Neurol. 2007, 49(3):210-213.
51. Van Amelsvoort T., Daly E., Henry J., Robertson D., Ng V., Owen M., Murphy K.C., Murphy D.G.M. Brain anatomy in adults with velocardiofacial syndrome with and without Schizophrenia: preliminary results of a structured magnetic resonance imaging study. Arch. Gen. Psychiatry 2004, 61:1085-1096.
52. Walker E., Lewine R.J. Prediction of adult-onset schizophrenia from childhood home movies of the patients. Am. J. Psychiatry 1990, 147:1052-1056.
53. Walker E., McMillan A., Mittal V. Neurohormones, neurodevelopment and the prodrome of psychosis in adolescence. Adolescent Psychopathology and the Developing Brain: Integrating Brain and Prevention Science 2007, Oxford University Press, New York. D. Romber, E. Walker (Eds.).
54. Webb C.T., Levinson D.F. Schizotypal and paranoid personality disorder in the relatives of patients with Schizophrenia and affective disorders: a review. Schizophr. Res. 1993, 11(1):81-92.
55. Willhite R.K., Niendam T.A., Bearden C.E., Zinberg J., O'Brien M.P., Cannon T.D. Gender differences in symptoms, functioning and social support in patients at ultra-high risk for developing a psychotic disorder. Schizophr. Res. 2008, 104:237-245.
56. Woods S.W., Addington J., Cadenhead K.S., Cannot T.D., Cornblatt B.A., Heinssen R., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., McGlashan T.H. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal study. Schizophr. Bull. 2009, 35(5):841-843.
57. Yung A.R., Phillips L.J., Pan Yuen H., Francey S.M., McFarlane C.A., Hallgren M., McGorry P.D. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr. Res. 2003, 60(1):21-32.
58. Zinkstok J., van Amelsvoort T. Neuropsychological profile and neuroimaging in patients with 22q11.2 deletion syndrome: a review. Child Neuropsychol. 2005, 11:21-37.